Get Your Own businessabc Wiki

Boost credibility, visibility, and discoverability

Last Updated: 2026

Apollo Endosurgery

Rank#5193

Market Cap579.72M

CountryUnited States

Summary

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.

History

Apollo Endosurgery was founded in 2002 by Dr. Robert Rainer, MD, and has grown steadily into a world-class medical devices company dedicated to reducing the invasiveness of therapeutic treatments.

Mission

At Apollo Endosurgery, our mission is to bring innovative, minimally-invasive therapies to people around the world for the treatment of obesity and other gastrointestinal diseases.

Vision

Our vision is to become a world leader in the development and manufacturing of endoscopic and laparoscopic surgical technology that improves healthcare delivery and patient outcomes.

References

https://in.investing.com/equities/lpath-inc

https://www.comparably.com/companies/vision/mission

https://www.crunchbase.com/organization/apollo-endosurgery

https://finance.yahoo.com/quote/APEN/

https://www.apolloendo.com

https://sec.report/CIK/0001251769

Leadership team

Mr. Charles S. McKhann (CEO, Pres & Director)

Mr. Jeffrey G. Black (CFO, Sec. & Treasurer)

Mr. John J. Molesphini (Exec. VP of Operations)

Products / Services

Biotechnology, Health Care, Medical Device

Number of Employees

100 - 500

Address

Austin, Texas, United States

Established

2006-01-01

Company Registration

SEC CIK number: 0001251769

Revenue

20M - 100M

Traded as

APEN

Website

https://www.apolloendo.com

Social Media

Last Updated: 2026

Get Your Own businessabc Wiki

Boost credibility, visibility, and discoverability

Learn More

Last Updated: 2026

Apollo Endosurgery

Rank#5193

Market Cap579.72M

CountryUnited States

Summary

History

Apollo Endosurgery was founded in 2002 by Dr. Robert Rainer, MD, and has grown steadily into a world-class medical devices company dedicated to reducing the invasiveness of therapeutic treatments.

Mission

At Apollo Endosurgery, our mission is to bring innovative, minimally-invasive therapies to people around the world for the treatment of obesity and other gastrointestinal diseases.

Vision

Our vision is to become a world leader in the development and manufacturing of endoscopic and laparoscopic surgical technology that improves healthcare delivery and patient outcomes.

References

https://in.investing.com/equities/lpath-inc

https://www.comparably.com/companies/vision/mission

https://www.crunchbase.com/organization/apollo-endosurgery

https://finance.yahoo.com/quote/APEN/

https://www.apolloendo.com

https://sec.report/CIK/0001251769

Leadership team

Mr. Charles S. McKhann (CEO, Pres & Director)

Mr. Jeffrey G. Black (CFO, Sec. & Treasurer)

Mr. John J. Molesphini (Exec. VP of Operations)

Products / Services